Page 16 - Sight Sciences News Today

MENLO PARK, Calif., July 19, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative...

Joe Manchin has long been a top recipient of campaign contributions from the energy sector, and last quarter’s data shows that trend has continued.

Cataract surgery is one of the most commonly performed procedures worldwide. Technological advances for preoperative assessment, IOL power calculation and surgical precision have increased safety and predictability, and the market offers a wide range of IOL options to satisfy patients’ needs. Nevertheless, unforeseen complications may occur, and some patients may be dissatisfied with their

Sight Sciences is seeing rapid revenue growth and over half of its market cap is net cash. Why am I still not enthusiastic about SGHT stock? Find out.

Sight Sciences (NASDAQ:SGHT – Get Rating) is one of 216 public companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its peers? We will compare Sight Sciences to similar companies based on the strength of its earnings, valuation, profitability, dividends, institutional ownership, analyst recommendations and risk. Valuation and […]

FinancialContent fully hosted finance channel

Investment Analysts’ upgrades for Tuesday, May 31st: Amundi (OTCMKTS:AMDUF) was upgraded by analysts at Keefe, Bruyette & Woods from a market perform rating to an outperform rating. Aperam (OTCMKTS:APEMY) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating. China Gas (OTCMKTS:CGHLY) was upgraded by analysts at Daiwa Capital […]

Sight Sciences (NASDAQ:SGHT – Get Rating) is one of 213 public companies in the “Surgical & medical instruments” industry, but how does it compare to its peers? We will compare Sight Sciences to similar companies based on the strength of its institutional ownership, risk, dividends, analyst recommendations, valuation, profitability and earnings. Insider & Institutional Ownership […]

Nuvectra (OTCMKTS:NVTRQ – Get Rating) and Sight Sciences (NASDAQ:SGHT – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings. Analyst Recommendations This is a summary of current ratings and […]

Sight Sciences (NASDAQ:SGHT – Get Rating) is one of 213 public companies in the “Surgical & medical instruments” industry, but how does it contrast to its peers? We will compare Sight Sciences to similar companies based on the strength of its institutional ownership, valuation, profitability, risk, dividends, analyst recommendations and earnings. Insider and Institutional Ownership […]